1.Meta analysis of the efficacy of digital psychological therapies on depressive symptoms among adolescents
YANG Xuan, YANG Dong, CAI Rui, TANG Yuping, YE Sheng, LUO Yaoyue
Chinese Journal of School Health 2026;47(4):531-537
Objective:
To systematically evaluate the therapeutic efficacy and maintenance effects of digital psychological therapies on depressive symptoms among adolescents, so as to provide a reference for clinical practice.
Methods:
Randomized controlled trial(RCT) investigating digital psychological therapies to improve depressive symptoms among adolescents were searched across databases, including PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang database, VIP database, and SinoMed, from database inception to November 20, 2025. Following literature screening, quality assessment, and data extraction, a Meta analysis was performed using Stata 18.0 software.
Results:
A total of 20 studies involving 2 042 adolescents aged 11-19 were included. The Meta analysis revealed that digital psychological therapies significantly alleviated depressive symptoms in adolescents ( SMD =-0.59, 95% CI =-0.85 to -0.32, P <0.01). The therapeutic effect was sustained at long term follow up ( SMD =-0.21, 95% CI =-0.34 to -0.09, P <0.01). Furthermore, depression scores in the intervention group showed a continued decrease from post intervention to long term follow up ( SMD =-0.28, 95% CI =-0.41 to -0.14, P <0.01). Egger s linear regression test indicated possible publication bias (Kendall s tall=0.28, P <0.01).
Conclusions
Digital psychological therapies can effectively improve depressive symptoms among adolescents, with stable long term efficacy. However, current evidence remains limited and exhibits substantial heterogeneity. Therefore, further large sample, high quality RCTs are warranted to validate the effectiveness of this intervention.
2.Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacologicalTreatments for Irritable Bowel Syndrome
Chengwen LI ; Qiong LIU ; Jianan CAO ; Xuan XU ; Haolong HE ; Yingchun HUANG ; Xinye LIU ; Rong LUO ; Xiaorong CHANG ; Mi LIU
Journal of Neurogastroenterology and Motility 2026;32(2):276-289
Background/Aims:
Non-pharmacological treatments are crucial for managing irritable bowel syndrome (IBS), yet patient engagement remains a challenge. Understanding patients' knowledge, attitudes, and practices regarding these treatments is essential for improving care.
Methods:
A cross-sectional study was conducted across 5 hospitals, from October 2023 to February 2024. A self-designed knowledge, attitudes, and practices questionnaire along with the IBS quality of life and IBS severity scoring system was administered, and 496 valid responses were analyzed. Statistical analyses included correlation tests, multivariate linear regression, and mediation effect analysis.
Results:
The median scores for knowledge, attitude, and practice were 28, 25.5, and 21, respectively. Significant positive correlations were found between knowledge-attitude (r = 0.195), knowledge-practice (r = 0.364), and attitude-practice (r = 0.151). The multivariate linear regression analysis further indicated that knowledge (β = 0.399, P < 0.001) and attitude (β = 0.219, P = 0.022) positively correlated with the practical performance. SEM revealed that knowledge had a significant direct effect on both attitude (β = 0.186, P = 0.013) and practice (β = 0.356, P = 0.006). However, the direct effect of attitude on practice was not significant, and attitude did not mediate the relationship between knowledge and practice.
Conclusions
IBS patients exhibit a significant gap between their positive attitudes and their actual practices concerning non-pharmacological treatments. Knowledge is a direct driver of practice, but positive attitudes alone are insufficient to translate into behavior. Healthcare providers must move beyond simply fostering positive attitudes and focus on targeted educational interventions that provide actionable knowledge and skills to improve patient outcomes.
3.Role and mechanism of semaphorins in liver diseases
Manwula MUBARESI ; Xuan DING ; Yidan LUO ; Qingshuai LIANG ; Xu ZHOU ; Yuwu LIU
Journal of Clinical Hepatology 2026;42(6):1454-1461
The liver is a vital metabolic organ sustaining human life activities, and its dysfunction is closely associated with various liver diseases. In recent years, an increasing number of studies have shown that semaphorins (SEMA) play a significant role in pathological processes such as immune inflammatory response, tumor progression, and fibrosis in liver diseases by interacting with their receptors plexins and neuropilins. This article reviews the expression, functions, and molecular mechanisms of different SEMA in viral hepatitis, hepatocellular carcinoma, liver fibrosis, nonalcoholic fatty liver disease, and hepatic ischemia-reperfusion injury, and it also explores the potential application value of SEMA in the diagnosis and treatment of liver diseases, in order to provide new ideas for precise diagnosis and targeted treatment of liver diseases.
4.Hemophagocytic syndrome secondary to visceral leishmaniasis: a case report
Chinese Journal of Schistosomiasis Control 2026;38(3):330-332
This article presents the diagnosis and treatment of a case with hemophagocytic syndrome secondary to visceral leishmaniasis. The patient had been misdiagnosed for a long period of time, and was finally definitively diagnosed as hemophagocytic syndrome secondary to visceral leishmaniasis through laboratory tests, bone marrow smear microscopy, and metagenomics next-generation sequencing. Due to unsatisfactory therapeutic efficacy, the patient's family members decided to abandon treatment, and the patient subsequently died following discharge from hospital.
5.Inflammation-driven Epithelial Remodeling and Persistent Cell-death Signaling Provide New Clues to Inflammatory Bowel Disease Relapse——a Commentary on Pang et al.’s Paper in Science (2026)
Xuan DONG ; Jia-Qi ZHANG ; Lian-Xiang LUO
Progress in Biochemistry and Biophysics 2026;53(10):2733-2738
Inflammatory bowel disease (IBD) is a chronic disorder characterized by recurrent mucosal inflammation. Although biologics and small-molecule therapies can effectively suppress inflammation, only 13%-34% of patients achieve deep histological remission, and most experience relapse within 2-3 years. Existing biomarkers, including C-reactive protein (CRP), fecal calprotectin, and endoscopic measures, have limited ability to detect subclinical molecular abnormalities, suggesting that disease-driving factors may persist even during clinical remission. Recently, Pang et al. reported a study in Science that investigated the role of epithelial cell-death signaling using a prospective adult IBD cohort comprising 80 participants and more than 900 biopsy specimens. By integrating bulk and spatial transcriptomics, patient-derived organoids, and 24-36 months of longitudinal follow-up, the authors characterized epithelial cell-death programs associated with IBD persistence. They found that the necroptosis-associated marker pRIPK3 could be detected in the absence of overt histological inflammation and persisted during advanced therapy. IFN‑γ and TNF reshaped the transcriptional landscape of specific colonic epithelial cells, inducing an inflammatory macrophage-like program termed cluster B and triggering RIPK1-independent RIPK3 signaling. This was followed by NOS2/iNOS-mediated mitochondrial apoptosis driving colonocyte death, whereas PUMA-dependent apoptosis contributed to intestinal stem-cell loss. Higher baseline pRIPK3 levels were associated with subsequent disease activity, although their independent predictive value remains to be established. These findings suggest that persistent IBD may reflect not only residual immune inflammation but also inflammation-induced pathological epithelial states. Future therapeutic strategies may therefore need to extend beyond inflammation control toward “molecular repair”, including targeting noncanonical RIPK3 signaling, modulating iNOS/PUMA-dependent mitochondrial apoptosis, and developing relapse-risk stratification strategies based on tissue biomarkers such as pRIPK3. Such approaches may help shift the therapeutic goal from “clinical remission” toward “molecular healing”.
6.Inhibition effect of secondary metabolites of Pseudomonas aeruginosa on Candida albicans and machanisms explore in vitro
Peng WANG ; Yuhang LUO ; Ping QIU ; Qi LI ; Jiawei LIU ; Linjuan CHEN ; Xuan CHEN ; Weihong WEN ; Lingqing XU
International Journal of Laboratory Medicine 2025;46(17):2097-2104
Objective To study the inhibitory effect of secondary metabolites of Pseudomonas aeruginosa(PA)on Candida albicans(CA)and to explore some of the mechanisms.Methods PA and CA strains were i-solated from clinical specimens from the hospital.Then,PA strains with inhibitory effects on CA were screened through cross-line test and co-incubation test,and crude extracts of PA secondary metabolites were prepared,and were tested together with pyocyanin,phenazine-1-carboxylic acid,1-hydroxyphenazine,and 3-ox-ododecyl-l-homoserine lactone(3-oxo-HSL).The inhibitory effects of various PA secondary metabolites on CA were determined through minimum inhibitory concentration test,minimum bactericidal concentration test,time-sterilization curve measurement,and XTT method activity measurement test,and some mechanisms by which PA secondary metabolites inhibited CA were explored.Results The strongest inhibitory effect on CA was 1-hydroxyphenazine,and at a concentration of 6.250 μg/mL,the relative activity of CA decreased to 0.00%.Next were pyocyanin and PA crude extract,and the relative fungal activity of CA decreased to 0.00%at concentrations of 200 and 100 μg/mL.1-hydroxyphenazine,pyocyanin,3-oxo-HSL and PA crude extract all had inhibitory effects on the formation of CA hyphae.Reactive oxygen species(ROS)were generated in CA cells treated with 1-hydroxyphenazine,phenazine 1-carboxylic acid,pyocyanin,and PA crude extract,and the highest levels of ROS were induced by pyocyanin and 1-hydroxyphenazine.Conclusion Phenazine secondary metabolites 1-hydroxyphenazine and pyocyanin have significant inhibitory effects on the growth and activity of CA,and both induce the highest amount of ROS.The quorum-sensing signal molecule 3-oxo-HSL have no in-hibitory effect on CA growth,but have a significant inhibitory effect on the formation of fungal hyphae.
7.Effects of horizontal rhythmic therapy combined with cardiopulmonary rehabilitation training on motor function in elderly patients with chronic heart failure
Li LUO ; Zhong YANG ; Xuan WANG
Journal of Navy Medicine 2025;46(11):1120-1125
Objective To investigate the effects of horizontal rhythmic therapy combined with cardiopulmonary rehabilitation training on the motor function of elderly patients with chronic heart failure(CHF).Methods A total of 86 elderly CHF patients admitted to Huai'an Second People's hospital between January 2021 and December 2023 were randomly assigned into experimental group or control group,with 43 cases in each group.The control group received conventional drug treatment and cardiopulmonary rehabilitation training,and the experimental group additionally received horizontal rhythmic therapy.The intervention lasted for 12 weeks.The left ventricular ejection fraction(LVEF),oxygen uptake at anaerobic threshold(VO? at),peak oxygen uptake(VO?peak),carbon dioxide equivalent slope(VE/VCO? slope),6-minute walk distance(6MWD),respiratory function(Borg score),health behavior(SRAHP score),C-reactive protein(CRP),N-terminal pro-brain natriuretic peptide(NT-proBNP),quality of life(MLHFQ score),and treatment compliance were compared between the two groups.Results After the intervention,the experimental group showed significantly improved LVEF,VO2 at,VO2 peak,6MWD,SRAHP score,along with lower VE/VCO2 slope,Borg score,CRP,NT-proBNP and MLHFQ score(all P<0.05).The experimental group had a higher rate of adherence to medical advice(P<0.05).Conclusion Horizontal rhythmic therapy combined with cardiopulmonary rehabilitation training can significantly improve cardiopulmonary efficiency,exercise capacity,respiratory efficiency,and overall quality of life,promote health behaviors and adherence to medical advice,and reduce inflammatory marker levels and cardiac load in elderly CHF patients.
8.Effects of respiratory training in PNF mode on exercise function and cardiopulmonary function in patients with chronic heart failure
Xuan WANG ; Jinqi LIU ; Li LUO
Journal of Navy Medicine 2025;46(11):1145-1149
Objective To explore the effects of respiratory training in proprioceptive neuromuscular facilitation(PNF)mode on exercise function and cardiopulmonary function in patients with chronic heart failure(CHF).Methods A total of 82 CHF patients admitted to Huai'an Second People's Hospital from October 2022 to July 2024 were enrolled and assigned to observation group or control group by a random number table,with 41 patients in each group.The control group underwent conventional rehabilitation training,while the observation group received respiratory training in PNF mode in addition to the conventional rehabilitation.Clinical efficacy,cardiac function indicators,such as E-wave,A-wave,stroke volume(SV),left ventricular ejection fraction(LVEF),and fractional shortening(FS),serum NT-proBNP,and 6-min walking distance(6MWD)were evaluated.Results After 8 weeks of intervention,the total effective rate,E-wave,SV,LVEF,and FS in the observation group were significantly higher than those in the control group(P<0.05),A-wave and serum NT-proBNP in the observation group were significantly lower than those in the control group(P<0.05),the 6MWD in the observation group was significantly longer than that in the control group(P<0.05).Conclusion Respiratory training in PNF mode is more effective than conventional rehabilitation,significantly improving exercise tolerance in CHF patients,left ventricular diastolic and systolic function.Additionally,it shows greater efficacy in reducing heart failure-related biochemical markers.As an adjunctive therapy in the rehabilitation of heart failure patients,it holds high clinical application value.
9.Comparison of neuroprotective effects of hUC-MSCs-Exos on hypoxic-ischemic brain injury in neonatal mice by different administration modes
Xiao-Xia HU ; Yi-Pa SAI ; Xing-Xing CHEN ; Wei-Jing CUI ; San-Ping WANG ; Xuan LUO ; Shi-Li WU
Medical Journal of Chinese People's Liberation Army 2025;50(2):207-213
Objective To investigate the comparative neuroprotective effects of human umbilical cord mesenchymal stem cells(hUC-MSCs-Exos)administered via different routes on hypoxic ischemic brain damage(HIBD)in neonatal mice.Methods Healthy one-week-old SPF-grade BALB/c mice were randomly divided into 4 groups:sham operation group(n=6),model group(n=6),exosome group 1(n=8),exosome group 2(n=8).HIBD was induced using the Rice-Vannucci method.Exosome group 1 and Exosome group 2 were intraperitoneal injection/intranasal drip of phosphate buffer(PBS)100 μl containing 10 μl exosomes within 24 h after successful modeling,respectively.Sham operation and model groups were intraperitoneal injection of PBS 100 μl.On the 7th day after the intervention,neuromotor function was assessed using the horizontal grid test and pole climbing test.On the 2nd day after the evaluation,all mice were killed and their brains were removed by decapitation.HE staining was used to observe the pathological injury of brain tissue,toluidine blue staining was used to observe the survival of neurons in cerebral cortex,and TUNEL staining was used to observe the apoptosis of cerebral cortex cells.Results Compared with sham operation group,model group,exosome group 1 and exosome group 2 exhibited increased hind limb drops in horizontal grid test and climbing scores(P<0.05).No significant difference was found in model group,exosome group 1 and exosome group 2 in these measures(P<0.05).Significant pathology was observed in model group,exosome group 1 and exosome group 2 compared to sham operation group(P<0.05),with significantly reduced damage in exosome group 1 and exosome group 2 compared to model group(P<0.05).Compared with sham operation group,Nissl body count was lower in model group and exosome group 1 and exosome group 2,with a higher count in exosome group 2 compared to exosome group 1(P<0.05).Compared with sham operation group,apoptotic cells were higher in model group and exosome group 1 and exosome group 2,with a significant reduction in exosome group 1 and exosome group 2 compared to model group,and the lowest in exosome group 2(P<0.05).Conclusions hUC-MSCs-Exos can improve the neuronal motor function,promote neuron repair and inhibit apoptosis in HIBD mice.Intranasal administration of hUC-MSCs-Exos is more effective than intraperitoneal administration for reducing neuronal apoptosis in HIBP neonatal mice,offering a convenient and rapid method suitable for clinical application.
10.Relationship between the Platelet Autophagy-related Factor Expression and Peritoneal Metastasis of Gastric Cancer
Xiaoxiao FAN ; Xuan ZENG ; Pingping ZHOU ; Xi LIU ; Feifei ZHU ; Yanji LUO ; Yi WU
Journal of Kunming Medical University 2025;46(7):125-130
Objective To investigate the relationship between the expression of platelet autophagy related factors and peritoneal metastasis of gastric cancer.Methods The data of 360 patients with gastric cancer who underwent surgery in Hunan Provincial People's Hospital from January 2021 to May 2023 were reviewed.Patients were divided into non-peritoneal metastasis group(n=322)and peritoneal metastasis group(n=38)according to whether peritoneal metastasis occurred or not.The following information was collected:patient's personal information(i.e.age,sex,body mass index)and tumor characteristics(i.e.location,size,pathological type,histopathological differentiation,lymphatic infiltration).Platelets were collected from all subjects,and the levels of autophagy-associated protein 7(ATG7),benzalkonium chloride 1(BECN1),microtubule-associated protein 1 light chain 3(LC3)and sequestosome 1(p62)were measured by enzyme-linked immunosorbent assay(ELISA).Results Among the 360 patients included,peritoneal metastasis was detected in 38 cases.Compared with the non-peritoneal metastasis group,the peritoneal metastasis group exhibited decreased BMI(P<0.05),while the tumor size,non-ulcerative tumor,number of lymph node metastasis,infiltration depth,number of cases of lymphatic invasion,platelet count,platelet LC3-Ⅱ level,platelet ATG7 level and CEA level were increased(P<0.05).Multivariate logistic regression analysis showed that BMI(OR=1.094),lymphatic invasion(OR=2.658),and LC3-Ⅱ(OR=3.793)and ATG7(OR=2.010)were independent influencing factors for peritoneal metastasis in patients with gastric cancer(P<0.05).LC3-Ⅱ>2.59ng/ml had the highest ability to predict peritoneal metastasis in patients with gastric cancer(AUC=0.932),followed by ATG7(AUC=0.916).Conclusions Elevated levels of platelet LC3-Ⅱ and ATG7 are independently related to peritoneal metastasis in patients with gastric cancer,and can be used to predict the occurrence of peritoneal metastasis,which is helpful to guide individualized treatment.


Result Analysis
Print
Save
E-mail